Navigation Links
Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8%
Date:2/27/2012

>http://www.watson.com.

About Columbia LaboratoriesColumbia Laboratories, Inc. is developing products that utilize its novel bioadhesive drug delivery technologies to optimize drug delivery in a controlled, sustained manner. The Company has developed and sold six products for the U.S. market including CRINONE® (progesterone gel), for which Columbia receives royalties on annual net sales from Watson Pharmaceuticals.  CRINONE is commercialized outside the U.S. by Merck Serono.  Columbia's press releases and other company information are available online at http://www.columbialabs.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This communication contains forward-looking statements, which statements are indicated by the words "may," "will," "plans," "intends," "believes," "expects," "anticipates," "potential," "could," "would," "should," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those projected in the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made. Factors that might cause future results to differ include, but are not limited to, the following: success in obtaining timely approval, if any, of a new drug application (NDA) by the U.S. Food and Drug Administration (FDA) for progesterone vaginal gel 8% for the preterm birth indication; the timing and level of success of a future product launch, if any; successful development of a next-generation vaginal progesterone product; difficulties or delays in manufacturing; the availability and pricing of third party sourced products and materials; successful compliance with FDA and other governmental regulations applicable to manufacturing facilities,
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Watson to Present at the 2012 RBC Capital Markets Healthcare Conference
2. Watson to Present at the Citi 2012 Global Healthcare Conference
3. Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
4. Watson Provides Update on Generic Lidoderm® Application
5. Watson Reaches Settlement with Mallinckrodt Over Exalgo(R)
6. Watson Confirms Court Stays Preliminary Injunction
7. Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
8. Watson Acquires Ascent Pharmahealth for AU$375 Million
9. Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
10. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
11. Watson Launches Generic LoSEASONIQUE(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Varian Medical Systems UK Ltd announced today it ... and service two new national NHS proton therapy centers in ... proton therapy system. Earlier this year, Varian announced that ... NHS centers to be constructed in London ... book the equipment portion of the order in its fiscal ...
(Date:7/27/2015)... 27, 2015   Iagnosis , the creator ... in online dermatology solutions, announced today its 2015 ... company has contractual relationships with dermatologists in 30 ... Dermatologists and Extenders Since December 2014, ... number of providers delivering care through the platform, ...
(Date:7/27/2015)... , July 27, 2015  Relmada Therapeutics, Inc. ... for the treatment of chronic pain, today announced ... (CTA) with Heath Canada to conduct ... d-Methadone (dextromethadone, REL-1017), its novel, N-methyl-D-aspartate (NMDA) receptor ... pain. "We are very encouraged by ...
Breaking Medicine Technology:Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 2Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 4Iagnosis Reports Significant Growth YTD 2015 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 2Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Multiple Ascending Dose Study with Promising NMDA Receptor Antagonist d-Methadone 3
... 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... data regarding its SCORPION(TM) multispecific therapeutic technology at ... of Cancer Research (AACR) in Denver, April 18-22, ... data demonstrating the selectivity and high potency of ...
... Agonist to Advance for Treatment of AllergySAN DIEGO , ... company focused on the development of novel Toll-Like Receptor ... and inflammatory diseases, announced today that it has initiated ... intranasal TLR8 agonist for the treatment of allergic rhinitis. ...
Cached Medicine Technology:Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3VentiRx Pharmaceuticals Initiates Phase I Clinical Trial of VTX-1463, a Novel TLR8 Agonist for the Treatment of Allergic Rhinitis 2
(Date:7/28/2015)... ... July 28, 2015 , ... Want to improve your ... or in your easy chair? Luckily, there are plenty of back-friendly cardio exercises that ... orthopedic spine surgeon at Atlantic Spine Center . , It’s simply untrue ...
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, ... offer behavioral health counseling for persons who are obese and those who are overweight ... clear. , That mandate will affect any commercial health plan with a program year ...
(Date:7/27/2015)... ... July 28, 2015 , ... The National Association of ... the NAPW VIP Woman of the Year Circle. She is recognized with this prestigious ... Local Chapters, NAPW is the nation’s leading networking organization exclusively for professional women. , ...
(Date:7/27/2015)... ... , ... The heroin epidemic is affecting the Charlotte in North Carolina equally ... rate for heroin usage has continued to climb around the country in part because ... alternative for those with an addiction to prescription opiate medications. According to WCNC, the ...
(Date:7/27/2015)... ... 27, 2015 , ... Looking to brush up on all the things you ... New Jersey has enhanced its Dental webpage with new materials, including user-friendly, educational videos, ... “Horizon is committed to offering our 3.8 million members tools and resources to help ...
Breaking Medicine News(10 mins):Health News:Safe Cardio for Back Pain Sufferers 2Health News:Safe Cardio for Back Pain Sufferers 3Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:NAPW Inducts Deana Skidmore, Assistant Director of Nursing at Wilton Meadows Rehablilitation and Health Care Center, Into its VIP Woman of the Year Circle 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 2Health News:45% Of People Addicted to Heroin Began Addicted to Prescription Medications 3Health News:Thinking about a Dental Check-up? Check out Horizon Blue Cross Blue Shield of New Jersey’s Enhanced Website for a Dental Download of Helpful Information 2
... of studies,School-based sexual abuse prevention programs can teach children ... ,However, the programs have a downside: they ... the review cautions. ,,It was a concern that ... review, but we were pleased that there was an ...
... every time you feel a cold starting isnt such a good ... will most probably end up getting the sniffles . ... over several decades and including more than 11,000 people who took ... ,The review, according to the researchers at the Australian National ...
... of pregnancy rumours once again when she was pictured with ... York premiere of John Travolta starrer Hairspray dressed in a ... reports the Daily Mail. ,Holmes sparked off rumours ... child when she was spotted with bump while visiting new ...
... Sreemathi Wednesday said the government was not averse to inviting ... of a mosquito borne fever in the state that has ... different expert teams have arrived in the state since the ... reports, which have confirmed the fever as chikunguniya and nothing ...
... reserved seats for students suffering from AIDS and cancer in ... reserved one seat for each of the fifty-six courses that ... cancer. ,However, the university feels that one seat ... being, since it do not expects many patients queuing up ...
... that set out to assess the effectiveness and tolerability ... methods of contraception found that they were all good ... implant was found to be any more or less ... ,,The most common side effect with all the implants ...
Cached Medicine News:Health News:School-based Sexual Abuse Prevention Programs 2Health News:School-based Sexual Abuse Prevention Programs 3
This design features a solid red iris....
This camouflaging lens features the solid black stripes of the lightning fast African zebra, on a white iris background....
Sphere Introducer...
Reusable cannula with .90 mm (20 g) shaft, tapering to .30 mm (30 g). Angled 125 3 mm from tip and flattened for easy insertion into the subretinal space....
Medicine Products: